Cargando…

The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit

Alzheimer’s disease (AD) is the leading cause of dementia, and many studies have focused on finding effective blood biomarkers for the accurate diagnosis of this disease. Predicting cerebral amyloid deposition is considered the key for AD diagnosis because a cerebral amyloid deposition is the hallma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Haeng Jun, Park, Jong-Chan, Jung, Keum Sim, Kim, Jiyeong, Jang, Ji Sung, Kwon, Sunghoon, Byun, Min Soo, Yi, Dahyun, Byeon, Gihwan, Jung, Gijung, Kim, Yu Kyeong, Lee, Dong Young, Han, Sun-Ho, Mook-Jung, Inhee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257730/ https://www.ncbi.nlm.nih.gov/pubmed/34108650 http://dx.doi.org/10.1038/s12276-021-00638-3

Ejemplares similares

Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2021)

Application of QPLEX(TM) biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition
por: Lee, Dongjoon, et al.
Publicado: (2022)

The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer’s Disease
por: Na, Hunjong, et al.
Publicado: (2023)

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
por: Park, Jong-Chan, et al.
Publicado: (2023)

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
por: Kim, Taewon, et al.
Publicado: (2022)

Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints
por: Kim, Jee Wook, et al.
Publicado: (2019)

Amyloid Beta-Mediated Epigenetic Alteration of Insulin-Like Growth Factor Binding Protein 3 Controls Cell Survival in Alzheimer's Disease
por: Sung, Hye Youn, et al.
Publicado: (2014)

Serum zinc levels and in vivo beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2021)

Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2017)

Serum Adiponectin and In Vivo Brain Amyloid Deposition in Cognitively Normal Older Adults: A Cohort Study
por: Kim, Jee Wook, et al.
Publicado: (2023)

Acute ER stress regulates amyloid precursor protein processing through ubiquitin-dependent degradation
por: Jung, Eun Sun, et al.
Publicado: (2015)

Association of low meal frequency with decreased in vivo Alzheimer’s pathology
por: Kim, Jee Wook, et al.
Publicado: (2022)

Genetic associations of in vivo pathology influence Alzheimer’s disease susceptibility
por: Seo, Jieun, et al.
Publicado: (2020)

Coffee intake and decreased amyloid pathology in human brain
por: Kim, Jee Wook, et al.
Publicado: (2019)

Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment
por: Lee, Sun Hyung, et al.
Publicado: (2020)

Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
por: Han, Sun-Ho, et al.
Publicado: (2011)

Amyloid β‐induced elevation of O‐GlcNAcylated c‐Fos promotes neuronal cell death
por: Choi, Heesun, et al.
Publicado: (2018)

Cognitive reserve proxies, Alzheimer pathologies, and cognition
por: Ko, Kang, et al.
Publicado: (2022)

HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons
por: Kim, Chaeyoung, et al.
Publicado: (2012)

Special issue on neurodegenerative diseases and their therapeutic approaches
por: Kim, Jungsu, et al.
Publicado: (2015)

PRAK mediates Aβ-RAGE driven autophagy pathway
por: Kim, Yoonhee, et al.
Publicado: (2017)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

AlzPharm: integration of neurodegeneration data using RDF
por: Lam, Hugo YK, et al.
Publicado: (2007)

A quadrupolar two-photon fluorescent probe for in vivo imaging of amyloid-β plaques
por: Heo, Cheol Ho, et al.
Publicado: (2016)

The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
por: Kim, Dong Kyu, et al.
Publicado: (2019)

Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway
por: Liu, Tian, et al.
Publicado: (2017)

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial
por: Shcherbinin, Sergey, et al.
Publicado: (2022)

Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology
por: Park, Jong‐Chan, et al.
Publicado: (2022)

Mitochondria-Specific Accumulation of Amyloid β Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death
por: Cha, Moon-Yong, et al.
Publicado: (2012)

Low Serum Phosphorus Correlates with Cerebral Aβ Deposition in Cognitively Impaired Subjects: Results from the KBASE Study
por: Park, Jong-Chan, et al.
Publicado: (2017)

Spouse bereavement and brain pathologies: A propensity score matching study
por: Kim, Jee Wook, et al.
Publicado: (2022)

Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults
por: Moon, Seok Woo, et al.
Publicado: (2023)

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
por: Hey, John A., et al.
Publicado: (2018)

TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease
por: Salloway, Stephen, et al.
Publicado: (2023)

Enlarged perivascular spaces are associated with decreased brain tau deposition
por: Kang, Koung Mi, et al.
Publicado: (2022)

Development of a Cognitive Composite for Preclinical Alzheimer’s Disease in Korean Older Adults
por: Kim, Minjae, et al.
Publicado: (2023)

AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
por: Mizuno, Satoshi, et al.
Publicado: (2012)

Thrombospondin-1 protects against Aβ-induced mitochondrial fragmentation and dysfunction in hippocampal cells
por: Kang, Seokjo, et al.
Publicado: (2018)

Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline
por: Jeon, So Yeon, et al.
Publicado: (2023)

Body mass index and two-year change of in vivo Alzheimer’s disease pathologies in cognitively normal older adults
por: Lee, Seunghoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_huaufijpa7s6l4c5udb9rvl6n1